{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:52:17Z","timestamp":1791402737417,"version":"4.3.3"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to investigate whether probiotics are effective in improving symptoms of functional dyspepsia (FD) accompanied by anxiety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>There were 116 patients with FD accompanied by anxiety and 114 patients without anxiety. Each group was randomly divided into an intervention group and a control group. The intervention group received probiotics in addition to conventional acid suppression and gastric protection, as well as prokinetic treatments. The control group received conventional treatment plus a placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Before treatment, significant differences were observed in IL-1, IL-6, TNF-<jats:italic>\u03b1<\/jats:italic>, LPS, Zonulin, DAO, and I-FABP between patients with FD accompanied by anxiety and those without anxiety (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). Following the intervention with probiotics, the group with FD and anxiety experienced significant decreases in IL-1, IL-6, TNF-<jats:italic>\u03b1<\/jats:italic>, LPS, Zonulin, and DAO (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001), as well as significant reductions in the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) and the Hamilton Anxiety Scale (HAMA) scores (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). In contrast, the intervention group with FD but without anxiety had significant reductions in IL-6 and TNF-<jats:italic>\u03b1<\/jats:italic> (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05), along with a significant decrease in the PAGI-SYM score (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Binary logistic regression analysis further revealed that lower I-FABP values (OR\u202f=\u202f0.999, <jats:italic>p<\/jats:italic>\u202f=\u202f0.036), lower LPS values (OR\u202f=\u202f0.998, <jats:italic>p<\/jats:italic>\u202f=\u202f0.013), and probiotic intervention (OR\u202f=\u202f5.138, <jats:italic>p<\/jats:italic>\u202f=\u202f0.000) were significantly associated with symptom relief.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The intervention significantly improved the symptoms and anxiety scores of patients with FD and anxiety, and the changes in intestinal mucosal permeability indexes were closely related to symptom relief and anxiety improvement, Probiotic interventions may be an effective means of improving symptoms in patients with FD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p>identifier ChiCTR2300077847 <jats:uri>https:\/\/www.chictr.org.cn\/<\/jats:uri>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2025.1614705","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T11:27:11Z","timestamp":1750246031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical efficacy of probiotics in improving intestinal mucosal permeability for functional dyspepsia patients with anxiety"],"prefix":"10.3389","volume":"16","author":[{"given":"Kang-ming","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-bin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Han","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.anpedi.2021.05.021","article-title":"Functional gastrointestinal disorders frequency by Rome IV criteria","volume":"96","author":"Alonso-Bermejo","year":"2022","journal-title":"An. Pediatr."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1053\/j.gastro.2015.01.039","article-title":"Anxiety is linked to new-onset dyspepsia in the Swedish population: a 10-year follow-up study","volume":"148","author":"Aro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.51821\/86.1.10998","article-title":"Neuromodulating agents in functional dyspepsia: a comprehensive review","volume":"86","author":"Bosman","year":"2023","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"111311","DOI":"10.1016\/j.cellsig.2024.111311","article-title":"cAMP-PKA signaling pathway and anxiety: where do we go next?","volume":"122","author":"Chen","year":"2024","journal-title":"Cell. Signal."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"300060520982657","DOI":"10.1177\/0300060520982657","article-title":"Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies","volume":"49","author":"Drago","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.15403\/jgld-3325","article-title":"Association of Functional Dyspepsia with depression and anxiety: a systematic review","volume":"30","author":"Esterita","year":"2021","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.12688\/f1000research.20510.1","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","volume":"9","author":"Fasano","year":"2020","journal-title":"F1000Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref10","first-page":"162","article-title":"Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases","volume":"58","author":"Funaoka","year":"2010","journal-title":"Rinsho Byori"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/1028415X.2019.1646975","article-title":"Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial","volume":"24","author":"Haghighat","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"851482","DOI":"10.3389\/falgy.2022.851482","article-title":"Eosinophils, hypoxia-inducible factors, and barrier dysfunction in functional dyspepsia","volume":"3","author":"Hari","year":"2022","journal-title":"Front. Allergy"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1130989","DOI":"10.3389\/fpsyt.2023.1130989","article-title":"Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories","volume":"14","author":"Hassamal","year":"2023","journal-title":"Front. Psych."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1517\/14712598.2012.707179","article-title":"Probiotics use to treat irritable bowel syndrome","volume":"12","author":"Hosseini","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10620-020-06138-0","article-title":"Angiopoietin-2 is an early predictor for acute gastrointestinal injury and intestinal barrier dysfunction in patients with acute pancreatitis","volume":"66","author":"Huang","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1136\/bmjgast-2017-000144","article-title":"Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia","volume":"4","author":"Igarashi","year":"2017","journal-title":"BMJ Open Gastroenterol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3748\/wjg.v21.i6.1932","article-title":"Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China","volume":"21","author":"Jiang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.psyneuen.2019.104501","article-title":"Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: a transdisciplinary challenge","volume":"111","author":"Labanski","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-med-042320-014032","article-title":"The gut-brain Axis","volume":"73","author":"Mayer","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/13548506.2022.2141278","article-title":"Psychotherapy appears to improve symptoms of functional dyspepsia and anxiety: systematic review with meta-analysis","volume":"28","author":"Mikocka-Walus","year":"2023","journal-title":"Psychol. Health Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1756-0500-7-275","article-title":"Intestinal permeability in children\/adolescents with functional dyspepsia","volume":"7","author":"Neilan","year":"2014","journal-title":"BMC. Res. Notes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2174\/0113895575262104230928042150","article-title":"Cortisol as a target for treating mental disorders: a promising avenue for therapy","volume":"24","author":"Patel","year":"2024","journal-title":"Mini Rev. Med. Chem."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.scib.2021.09.007","article-title":"GABA(a)(\u03b4) receptor hypofunction in the amygdala-hippocampal circuit underlies stress-induced anxiety","volume":"67","author":"Qin","year":"2022","journal-title":"Sci. Bull."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3345\/cep.2019.01613","article-title":"Evaluating the effects of probiotics in pediatrics with recurrent abdominal pain","volume":"63","author":"Rahmani","year":"2020","journal-title":"Clin. Exp. Pediatr."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"8584","DOI":"10.1038\/s41598-025-93137-8","article-title":"Heart rate variability, daily cortisol indices and their association with psychometric characteristics and gut microbiota composition in an Italian community sample","volume":"15","author":"Ravenda","year":"2025","journal-title":"Sci. Rep."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s11136-004-9567-x","article-title":"Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders","volume":"13","author":"Rentz","year":"2004","journal-title":"Qual. Life Res."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e34938","DOI":"10.1371\/journal.pone.0034938","article-title":"A meta-analysis of probiotic efficacy for gastrointestinal diseases","volume":"7","author":"Ritchie","year":"2012","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"844564","DOI":"10.3389\/fnins.2022.844564","article-title":"Bi-directionality of the microbiota-gut-brain Axis in patients with functional dyspepsia: relevance of psychotherapy and probiotics","volume":"16","author":"Rupp","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s40265-020-01362-4","article-title":"Functional dyspepsia: diagnostic and therapeutic approaches","volume":"80","author":"Sayuk","year":"2020","journal-title":"Drugs"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1152\/ajpgi.00113.2021","article-title":"Biomarkers for assessment of intestinal permeability in clinical practice","volume":"321","author":"Seethaler","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","article-title":"Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression","volume":"67","author":"Stevens","year":"2018","journal-title":"Gut"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.12.023","article-title":"The brain-gut-Microbiotal Axis: a framework for understanding functional GI illness and their therapeutic interventions","volume":"84","author":"Tait","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/occmed\/kqv054","article-title":"Hamilton rating scale for anxiety (HAM-A)","volume":"65","author":"Thompson","year":"2015","journal-title":"Occup. Med."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/microorganisms11020351","article-title":"Probiotics in functional dyspepsia","volume":"11","author":"Tziatzios","year":"2023","journal-title":"Microorganisms"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"Cd012849","DOI":"10.1002\/14651858.CD012849.pub2","article-title":"Probiotics for management of functional abdominal pain disorders in children","volume":"2","author":"Wallace","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ueg2.12061","article-title":"United European gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia","volume":"9","author":"Wauters","year":"","journal-title":"United European Gastroenterol J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S2468-1253(21)00226-0","article-title":"Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial","volume":"6","author":"Wauters","year":"","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/gutjnl-2019-318536","article-title":"Novel concepts in the pathophysiology and treatment of functional dyspepsia","volume":"69","author":"Wauters","year":"2020","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.21037\/apm-20-2420","article-title":"D-galacturonic acid ameliorates the intestinal mucosal permeability and inflammation of functional dyspepsia in rats","volume":"10","author":"Wu","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e19107","DOI":"10.1097\/MD.0000000000019107","article-title":"Efficacy of prebiotics and probiotics for functional dyspepsia: a systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1614705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T11:27:12Z","timestamp":1750246032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1614705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":40,"alternative-id":["10.3389\/fmicb.2025.1614705"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1614705","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1614705"}}